| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.7227308868429015 2.733772891313454 0.0062613214812061 0.975878130890944 0.2063957608728241 14 P02545,P55209,P49354,O75844,O60725 5 |
| Familial partial lipodystrophy fpld 0.8256070126787602 2.453869081050298 0.0141328424478686 0.9997840711555444 0.293476799243817 8 P20700,P31751,P02545,P49354,O75844,O60725 6 |
| Nephrotic syndrome 0.6923962935181969 2.2663532932158907 0.0234297608704558 0.99999921626968 0.3969670913194384 12 Q14108,P02545,O75844,Q9BT22 4 |
| Folate metabolism 0.6935269570831762 2.145036351884361 0.0319499406244496 0.9999999956608482 0.4616298056994859 11 Q8WTV0,P41440 2 |
| Progeriaassociated lipodystrophy 0.7137981379679043 2.135802266790723 0.0326955342991204 0.9999999972522748 0.4616298056994859 10 P20700,P02545,P49354,O75844,O60725 5 |
| Constitutive androstane receptor pathway 0.8001651487284378 2.0782334457008775 0.0376878630013703 0.9999999998722484 0.50792960817756 6 P08183 1 |
| Influence of laminopathies on wnt signaling 0.6992197649614144 2.0628787626113048 0.0391241483525413 0.9999999999473138 0.5147476691783109 10 P49354,O75844,O60725 3 |
| Vitamin d receptor pathway 0.6443802885276906 2.007217223860686 0.0447265384378194 0.9999999999983566 0.5147476691783109 12 P08183,Q92783 2 |
| Allograft rejection 0.6778770818933804 1.9550841784109436 0.0505731353849785 0.9999999999999568 0.5147476691783109 10 P08670,P08183,P10321 3 |
| Acquired partial lipodystrophy barraquersimons syndrome 0.8421242774566362 1.9367202186916403 0.0527795528660504 0.9999999999999892 0.5147476691783109 5 P02545,P49354,P20700,O60725 4 |
| Pregnane x receptor pathway 0.7662554229453444 1.930502952050542 0.0535445497950037 0.9999999999999932 0.5147476691783109 6 P08183 1 |
| Sphingolipid metabolism integrated pathway 0.7565522511420623 1.8878205457473136 0.0590500459780933 0.9999999999999998 0.5147476691783109 6 Q96G23 1 |
| Sphingolipid metabolism overview 0.7565522511420623 1.8878205457473136 0.0590500459780933 0.9999999999999998 0.5147476691783109 6 Q96G23 1 |
| Vitamin a and carotenoid metabolism 0.8295940128840336 1.885628142786477 0.0593450822333769 0.9999999999999998 0.5147476691783109 5 Q8WTV0 1 |
| Striated muscle contraction pathway 0.8280346820809074 1.8792532397431512 0.0602099232008237 1.0 0.5147476691783109 5 P06753,P08670,P35609,P67936 4 |
| Adipogenesis 0.5979856809264833 1.8752175989003268 0.0607627940008124 1.0 0.5147476691783109 13 Q92879,P02545,O75844 3 |
| Mecp2 and associated rett syndrome 0.5401971989365186 1.84753435640596 0.0646697335606996 1.0 0.535854579342421 18 P35637,P31943,P52597,O75475,Q96ST3,Q99640 6 |
| Irinotecan pathway 0.9682425117286172 1.826354932000701 0.0677968157878234 1.0 0.535854579342421 2 P33527 1 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.7382173857296197 1.8066893105496895 0.0708107353241607 1.0 0.538343154451632 6 P04792 1 |
| Oxidation by cytochrome p450 0.7790787436502911 1.677332248380082 0.0934775298572467 1.0 0.6025236435363841 5 Q16850 1 |
| Nocgmppkg mediated neuroprotection 0.8824978278547666 1.6447521621992889 0.1000209310109365 1.0 0.611755276230099 4 P35609 1 |
| Ketogenesis and ketolysis 0.7706418370014245 1.6422101064999362 0.1005464689317001 1.0 0.611755276230099 5 P53985,O43772,P23786 3 |
| Sphingolipid pathway 0.6306424860539778 1.6200716373331008 0.1052168892318636 1.0 0.6302385385302541 9 Q96G23 1 |
| Mitochondrial complex i assembly model oxphos system 0.4834316056154225 1.5971676114159534 0.1102283502876073 1.0 0.6471822942628828 22 Q9P0J0,Q7L592,P51970,Q96CU9,O75306,Q8TB37,Q16718,O43676,O95168,O75489 10 |
| S1p receptor signal transduction 0.6173325262396289 1.552639897888826 0.1205091882988727 1.0 0.6515927843257145 9 P04899,Q9H0H5 2 |
| Initiation of transcription and translation elongation at the hiv1 ltr 0.6318979845017806 1.542760101430396 0.1228889933859451 1.0 0.6515927843257145 8 P18615,Q8WX92,Q8IXH7 3 |
| Alzheimers disease 0.3603952050432714 1.502738210677704 0.1329065651473842 1.0 0.6559657341808502 78 P21796,P07437,Q9Y277,P45880,P31751,Q9H0B6,Q99436,P68371,O00487,Q07866,Q9NQC3,P28074,Q13885,O15111,P28072,P60900,O95197,P49721,Q9NSK0,P49720,P28070,P42574 22 |
| Alzheimers disease and mirna effects 0.3596268309866188 1.4990988771654403 0.1338479828598362 1.0 0.6559657341808502 79 P21796,P07437,Q9Y277,P45880,P31751,Q9H0B6,Q99436,P68371,O00487,Q07866,Q9NQC3,P28074,Q13885,O15111,P28072,P60900,O95197,P49721,Q9NSK0,P49720,P28070,P42574 22 |
| Ferroptosis 0.4751264965306292 1.4809990835559812 0.1386068177003681 1.0 0.6709120100047075 20 P45880,P02786,P37268,P48507,P04792 5 |
| Statin inhibition of cholesterol production 0.8286241250755406 1.4367015002837429 0.1508028284959015 1.0 0.6808920008219915 4 Q8WTV0,P37268 2 |
| Genes related to primary cilium development based on crispr 0.5685548379102916 1.3856527834357244 0.1658529523518508 1.0 0.7049063047809084 10 O95684,Q10713,Q9Y496,Q9C0F1 4 |
| Eicosanoid metabolism via cyclooxygenases cox 0.6366111183406264 1.3474132507405323 0.1778471753187811 1.0 0.7158810013097706 6 Q8N8N7 1 |
| Congenital generalized lipodystrophy cgl 0.8293035005413179 1.2557414717924356 0.2092097178483625 1.0 0.7554854330317324 2 P31751 1 |
| Eicosanoid metabolism via lipooxygenases lox 0.6133676081043239 1.2407796751921438 0.2146871515167872 1.0 0.7559571358122805 6 Q8N8N7 1 |
| Proteasome degradation 0.3893628142174492 1.2284827168876524 0.2192658134227862 1.0 0.7559571358122805 42 P28074,P10321,P28072,Q9UL46,P49720,P49721,Q99436,O00231,P60900,P28070,Q06323,P01889 12 |
| Urea cycle and related diseases 0.8206423673763976 1.2202925954042103 0.2223539757781441 1.0 0.7577925726232152 2 Q9UJS0 1 |
| Tnfalpha signaling pathway 0.4402636458589508 1.210375017183604 0.2261350238258519 1.0 0.7619208473223307 19 Q9NR28,Q16543,P62993,P53350,P42574 5 |
| Mitochondrial long chain fatty acid betaoxidation 0.5026663286555244 1.205260762226989 0.2281026520106772 1.0 0.764208320013173 12 O43772 1 |
| Ccl18 signaling pathway 0.5600104821519345 1.1861774135913334 0.235552243930543 1.0 0.7745852058667733 8 P08670 1 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.5536319991944509 1.1543458847698265 0.2483583917362737 1.0 0.7959073818099268 8 P31943 1 |
| Male infertility 0.442227573235003 1.1414798026253326 0.2536703122463342 1.0 0.7959073818099268 17 P08183,Q15165,P41440 3 |
| Drug induction of bile acid pathway 0.8397055505057688 1.1236137137630215 0.2611769357595312 1.0 0.80036575856564 3 P08183 1 |
| Sphingolipid metabolism in senescence 0.5129736982772228 1.088939898148235 0.2761803903699447 1.0 0.8240240912628937 10 Q96G23 1 |
| Metapathway biotransformation phase i and ii 0.4140390725854439 1.08815320835319 0.2765274775064348 1.0 0.8240240912628937 22 Q06520,Q16850,O43708,P07099,P21964 5 |
| Nucleotidebinding oligomerization domain nod pathway 0.5508004933416785 1.07044241190536 0.2844202174554953 1.0 0.8308432953256587 7 Q7L5N1,Q9P0J0 2 |
| Cholesterol biosynthesis with skeletal dysplasias 0.5743494013469103 1.061641887160495 0.288398290352009 1.0 0.8362176399716673 6 Q16850 1 |
| Myometrial relaxation and contraction pathways 0.4278771750681557 1.0444927446689347 0.2962574742262833 1.0 0.8362176399716673 17 P27348,P16615,P31946,P10644,P78417,Q04917,P63218,Q05682,P62258,P19174,P61981 11 |
| Praderwilli and angelman syndrome 0.5305171706297026 1.0390554249495547 0.298778960128129 1.0 0.8362176399716673 8 Q8N8Q9 1 |
| Relationship between inflammation cox2 and egfr 0.6202013268091113 1.0079830327253765 0.3134626077812394 1.0 0.8578589107094712 5 P31751 1 |
| Aryl hydrocarbon receptor pathway wp2873 0.6148617071929757 0.9855701344253316 0.3243440995562483 1.0 0.8578589107094712 5 O00170,Q16543 2 |
| Cellular proteostasis 0.7103647526182609 0.9793687758555466 0.3273977992465573 1.0 0.8578589107094712 4 O15212,Q9UHV9,Q99471 3 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.6002803444038216 0.9246022547968092 0.3551728397473825 1.0 0.8578589107094712 5 Q9HB09 1 |
| 15q112 copy number variation syndrome 0.5977977582687242 0.9142620751467876 0.3605791533086364 1.0 0.8578589107094712 5 Q06787,Q8N8Q9 2 |
| Translation factors 0.3635640959646976 0.9044938446790604 0.3657335967824364 1.0 0.8578589107094712 36 O75153 1 |
| Integrinmediated cell adhesion 0.3961616447814002 0.8985473789595191 0.3688937980285247 1.0 0.8578589107094712 19 P31751,P62993,Q14155,O75116 4 |
| Ovarian infertility 0.7286178274990941 0.8517918803346498 0.3943296137703811 1.0 0.8897252086933999 2 P11802 1 |
| Amyotrophic lateral sclerosis als 0.426595030487049 0.8513051195420105 0.3945998817645264 1.0 0.8897252086933999 13 P07196,P20339,P07197,P42574 4 |
| Antiviral and antiinflammatory effects of nrf2 on sarscov2 pathway 0.7556175423141749 0.8210764535561977 0.4116027212418576 1.0 0.9041986794036326 3 P48507 1 |
| Chemokine signaling pathway 0.378706700446612 0.8095679497437741 0.4181885348020535 1.0 0.9041986794036326 21 P31751,P04899,O75116,P41240,P63218,P62993 6 |
| Methionine de novo and salvage pathway 0.471186004227007 0.8030195580670996 0.421963430253562 1.0 0.9041986794036326 9 Q9BV57 1 |
| Fatty acid betaoxidation 0.3820998345845379 0.8001269725625154 0.4236372351456112 1.0 0.9041986794036326 19 O43772,P40939,P23786,P35610 4 |
| Mrna protein and metabolite inducation pathway by cyclosporin a 0.7134608444604795 0.7934790648426521 0.4274987618567412 1.0 0.9041986794036326 2 P08195 1 |
| Ciliopathies 0.3940884782673557 0.7901060509888995 0.4294658363426031 1.0 0.9041986794036326 16 Q10713,Q9UBB4,O43924 3 |
| Hippoyap signaling pathway 0.7116564417177871 0.7866022948636671 0.4315147154658145 1.0 0.9041986794036326 2 Q13043 1 |
| Proximal tubule transport 0.4655159874597697 0.7744570916196828 0.4386605331172815 1.0 0.9127217408370102 9 Q9Y5K8,P08195,Q9UI12,P08183,P36543 5 |
| Burn wound healing 0.463751723863436 0.7655965604171169 0.4439163917126325 1.0 0.9157688419131422 9 P08670 1 |
| Degradation pathway of sphingolipids including diseases 0.5083432145271571 0.7629532046356101 0.4454913042163841 1.0 0.9157688419131422 6 O43681,P06865 2 |
| Ebola virus infection in host 0.3457412911493412 0.7582648259281353 0.4482924598423647 1.0 0.9157688419131422 37 O43707,P20339,P10321,P12814,Q9P253,O15118,P41440,P01889 8 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.3614426187055798 0.7434531651687954 0.4572073667051659 1.0 0.9190642998514014 24 P14324,P37268,O95864,Q15392,Q16850,P35610 6 |
| Pathways of nucleic acid metabolism and innate immune sensing 0.5009209737071483 0.7301596522433774 0.4652926020854546 1.0 0.9278354452208176 6 Q7Z434,O00584 2 |
| Omega3 omega6 fatty acid synthesis 0.4995489191147356 0.7241235751569396 0.4689898723487178 1.0 0.9301371046916042 6 O15254 1 |
| Primary focal segmental glomerulosclerosis fsgs 0.3731944959535889 0.7073901594561066 0.4793240505231293 1.0 0.9421575473369944 18 P08670,Q14108 2 |
| Proteoglycan biosynthesis 0.7202166064981921 0.6992768757891247 0.4843790154805707 1.0 0.9426302359803328 3 Q9NX62,Q8NCH0 2 |
| Apoptosisrelated network due to altered notch3 in ovarian cancer 0.4137854289035673 0.6966272029884021 0.4860361271581606 1.0 0.9426302359803328 12 P08670 1 |
| Chromosomal and microsatellite instability in colorectal cancer 0.3665257961112284 0.6369795279967888 0.524138178554852 1.0 0.9802798625265452 17 Q96KP1 1 |
| Copper homeostasis 0.4775571770251251 0.6286646741236664 0.529568609817872 1.0 0.9802798625265452 6 P35670 1 |
| Integrated cancer pathway 0.3732704367172166 0.6184077815467928 0.5363065696297018 1.0 0.9802798625265452 14 P11802,P43246,P06493,P53350,P42574 5 |
| Tryptophan metabolism 0.3680727655163639 0.6043588801853994 0.5456050678617324 1.0 0.9834158214042774 15 O94788,P40939,Q15392 3 |
| Kennedy pathway from sphingolipids 0.6064228665358555 0.5975588493219677 0.5501343288495755 1.0 0.9852274106156388 4 P35790 1 |
| Mirna regulation of p53 pathway in prostate cancer 0.5187085918754164 0.5953726015522053 0.5515944356229208 1.0 0.9852274106156388 5 O14681,P42574 2 |
| Spinal cord injury 0.346857964773881 0.5719362331222255 0.567365175875115 1.0 0.9932687641404544 20 P08670,Q9NQC3 2 |
| Cholesterol biosynthesis pathway 0.3759270366071194 0.5573649035727503 0.5772781394998572 1.0 1.0 13 P14324,Q16850,P37268,Q15800 4 |
| Il18 signaling pathway 0.300893721082877 0.5477679984222433 0.5838512148085964 1.0 1.0 52 P51858,P16949,O00425,P40939,Q8TCT8,Q9UMR5,P04792 7 |
| Arrhythmogenic right ventricular cardiomyopathy 0.3847646829893797 0.5388830117799566 0.5899675799261295 1.0 1.0 12 O43707,P35221,P12814,P02545,P35609 5 |
| Serine metabolism 0.4530888738748944 0.5259935384462733 0.5988926964775589 1.0 1.0 6 O43175 1 |
| Regulation of actin cytoskeleton 0.3208910958058569 0.5226010621929824 0.6012519012065618 1.0 1.0 32 Q9UQB8,Q14155 2 |
| P38 mapk signaling pathway 0.4129811387703681 0.5184302425162052 0.604158118767343 1.0 1.0 9 P05114,P04792 2 |
| Glycosaminoglycan degradation 0.4486847006913055 0.5079977696249245 0.6114549073699656 1.0 1.0 6 P06865,P08236,P54802 3 |
| Fas ligand pathway and stress induction of heat shock proteins 0.3491693469391728 0.4914467617598289 0.6231104975705044 1.0 1.0 15 P20700,P02545,Q03252,P04792,Q13813 5 |
| Mammary gland development pathway pregnancy and lactation stage 3 of 4 0.4908533727714992 0.4908224837251826 0.6235520063315576 1.0 1.0 5 P61201,P06753,O15111 3 |
| Supression of hmgb1 mediated inflammation by thbd 0.6279321544568679 0.4884615198367071 0.625222975483827 1.0 1.0 2 O15111 1 |
| Ncrnas involved in wnt signaling in hepatocellular carcinoma 0.4144665461121072 0.4821771998305815 0.6296800721927658 1.0 1.0 8 Q13363,Q15717,P56545,Q86UE4,P48729,P35222,P19784 7 |
| Disruption of postsynaptic signaling by cnv 0.4217350151766236 0.4730582988124657 0.6361715870021314 1.0 1.0 7 Q14168,Q06787,P61981 3 |
| Retinoblastoma gene in cancer 0.3035635334243011 0.4506199082342302 0.6522635156787762 1.0 1.0 45 Q14566,P16949,Q16204,Q96ST3,P09455 5 |
| Ciliary landscape 0.2765395359232881 0.4495619082893499 0.6530263594524768 1.0 1.0 90 O15173,Q14566,Q92600,P06280,Q92769,Q96A65,O95400,Q96S59,Q96KP1,Q9Y6G9,P10619,P61201,Q16718,Q9UL25,P08670,A0AVF1,Q7L5N1,P07196,Q9BT78,P60660,P07197,Q99627 22 |
| Mfap5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement 0.4155504683414619 0.4470262573998825 0.6548561015125827 1.0 1.0 7 P12814,P19174 2 |
| Physicochemical features and toxicityassociated pathways 0.3388092898921124 0.4317462668685482 0.6659258366209166 1.0 1.0 15 P07196,O75116 2 |
| Pdgfrbeta pathway 0.4024238185196884 0.4294510222052795 0.6675950296894015 1.0 1.0 8 P62993,P20936 2 |
| Notch signaling 0.4675778124351362 0.4082378431941917 0.6830990675541506 1.0 1.0 5 Q92769 1 |
| Regulation of wnt bcatenin signaling by small molecule compounds 0.598700830025254 0.3973657389241127 0.6910977765041664 1.0 1.0 2 P48729 1 |
| Tcell antigen receptor tcr pathway during staphylococcus aureus infection 0.3440274708541827 0.3860701324607809 0.6994447291346266 1.0 1.0 13 O15111,P62993,O95999,P19174 4 |
| Monoamine transport 0.6175762658339268 0.3825517143321866 0.702052177898371 1.0 1.0 3 O15127 1 |
| Aryl hydrocarbon receptor pathway wp2586 0.4165646504893749 0.3823238519651382 0.7022211647836318 1.0 1.0 6 Q16543 1 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.38276264976926 0.3821694153221954 0.7023357061843807 1.0 1.0 9 P31751 1 |
| Sarscov2 innate immunity evasion and cellspecific immune response 0.3796335941792551 0.3687068960710625 0.7123462080475249 1.0 1.0 9 Q7Z434,Q92769 2 |
| G1 to s cell cycle control 0.3053301581972638 0.3628659930961181 0.7167049913459032 1.0 1.0 25 Q14566,Q9UBD5,Q9Y619,P49642,Q14181,Q99640 6 |
| Joubert syndrome 0.3234232504541573 0.358048294093363 0.720307172573335 1.0 1.0 16 Q15154,Q10713,O43924 3 |
| Oxidative damage response 0.4082125886943025 0.3515005752316382 0.7252128410069305 1.0 1.0 6 O95429 1 |
| Mthfr deficiency 0.3723731590994046 0.3380091808230405 0.7353562692567581 1.0 1.0 9 P35790,P21964,Q7L592 3 |
| Mitochondrial complex iv assembly 0.3502547621679444 0.3190214264933113 0.7497102650571235 1.0 1.0 11 Q9Y2R0,P15954,P13073 3 |
| Mevalonate arm of cholesterol biosynthesis pathway 0.3468818413221446 0.3042021183377846 0.7609739110719171 1.0 1.0 11 P14324,P37268 2 |
| Sudden infant death syndrome sids susceptibility pathways 0.294493848566474 0.2925087115329367 0.7698977001630509 1.0 1.0 25 P42892 1 |
| Circadian rhythm genes 0.2884033895704323 0.288310261169162 0.7731092532124706 1.0 1.0 39 Q9UNS1,P23246,Q8WXF1,O75116,Q9BWF3,P00813,Q96ST3,P54802 8 |
| 22q112 copy number variation syndrome 0.2894507211325019 0.2844941893729337 0.7760316863657513 1.0 1.0 33 Q9NQ50,P43487,O94788,P53350,P21964,Q9NQC3,P45973 7 |
| Ethanol effects on histone modifications 0.3381802023625894 0.266967140787173 0.7894944609966121 1.0 1.0 11 O94788,P41440,Q92769 3 |
| Small cell lung cancer 0.3266630785269643 0.2557840388823079 0.7981175991509919 1.0 1.0 12 P31751,O15111,P42574 3 |
| Atm signaling in development and disease 0.2922714151264934 0.2467479704205552 0.8051032791034323 1.0 1.0 22 O75150,P49815,P04792 3 |
| Mitochondrial complex iii assembly 0.3399784883205279 0.2402072016475813 0.81016963099685 1.0 1.0 10 Q9UDW1,O14949 2 |
| Apoptosis 0.302264007234363 0.2328957366000547 0.8158423691262104 1.0 1.0 14 Q9NR28,Q9NRZ9,P42574,P42575 4 |
| Cohesin complex cornelia de lange syndrome 0.3010206046202192 0.2270985637159597 0.8203471008635652 1.0 1.0 14 Q9Y6X3,Q29RF7,P30154,P53350,P06493 5 |
| Apoptosis modulation and signaling 0.2990352427648745 0.2226731698345831 0.8237898844742491 1.0 1.0 15 Q9NR28 1 |
| Resistin as a regulator of inflammation 0.3558729437541644 0.2208001131844925 0.8252480754473275 1.0 1.0 7 P31751,O15111 2 |
| Calcium regulation in cardiac cells 0.2871717688650972 0.2175681336049342 0.827765615400057 1.0 1.0 22 Q9P246,P62258,P63218,P04899 4 |
| Pathogenic escherichia coli infection 0.2831298881294516 0.2121898873123172 0.8319588958713973 1.0 1.0 24 Q92974,Q13885,O75116,P68371,P07437 5 |
| Neural crest differentiation 0.4017341040462558 0.2068687512882633 0.8361123614729737 1.0 1.0 5 Q13547,P35222,P56545,Q92769 4 |
| Nrf2are regulation 0.3964927830874402 0.1933224997824542 0.8467064064154255 1.0 1.0 5 Q96HS1 1 |
| Base excision repair 0.2907391855979473 0.1841431256910582 0.8539011754916335 1.0 1.0 15 P18887,P18858 2 |
| Tlr4 signaling and tolerance 0.455851905058533 0.1696295937876739 0.8653014473465932 1.0 1.0 4 Q15629 1 |
| Pyrimidine metabolism and related diseases 0.337409336761745 0.1623661432047319 0.8710175308367114 1.0 1.0 7 Q9H0P0 1 |
| Onecarbon metabolism and related pathways 0.3022589127860752 0.1569483456714279 0.8752855576309373 1.0 1.0 12 P35790 1 |
| Tnfrelated weak inducer of apoptosis tweak signaling pathway 0.3062817425348692 0.1444151704472409 0.885172638096535 1.0 1.0 11 P31751,P42574 2 |
| Mevalonate pathway 0.3379110950487857 0.132659054375991 0.8944630264506452 1.0 1.0 6 Q15126,P14324,Q03426,P53602,Q9BWD1 5 |
| Cytosolic dnasensing pathway 0.3058728313426905 0.1197527010949043 0.9046790512690348 1.0 1.0 10 P55265,Q7Z434,O15111 3 |
| Glucocorticoid receptor pathway 0.420851353254957 0.1064729141697681 0.9152071445925598 1.0 1.0 4 Q86UP2 1 |
| Estrogen receptor pathway 0.4601226993864911 0.1040613460284236 0.917120665668836 1.0 1.0 2 Q15067 1 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.3520761206332151 0.0956609242539789 0.923789876448652 1.0 1.0 5 P07099 1 |
| Endometrial cancer 0.2808236190776774 0.0831275453795277 0.9337501235947732 1.0 1.0 12 P31751,P62993 2 |
| Mammary gland development pathway involution stage 4 of 4 0.4602888086642533 0.0801719545874707 0.9361004953408628 1.0 1.0 3 Q07812,P04637 2 |
| Leptininsulin signaling overlap 0.4602888086642531 0.0801719545874704 0.9361004953408628 1.0 1.0 3 O14654,P31749 2 |
| Ddx1 as a regulatory component of the drosha microprocessor 0.3406791907514472 0.0757179389248677 0.9396435037657436 1.0 1.0 5 Q8WYQ5,Q92499,P49959,Q92878 4 |
| Ras signaling 0.2521559891205912 0.0720160455729963 0.9425891384862995 1.0 1.0 27 P31751,Q96KP1,O15111,P63218,P62993,P20936,P20339 7 |
| Nonsmall cell lung cancer 0.2615529817704988 0.0704084336357043 0.9438685788388924 1.0 1.0 18 P11802,P31751,P62993,Q13043,Q07812,P19174,P42574 7 |
| T cell receptor and costimulatory signaling 0.3268233731571021 0.0542930701571534 0.9567016706252458 1.0 1.0 5 P20936 1 |
| Mammary gland development pathway embryonic development stage 1 of 4 0.4012991699747307 0.0527765524380933 0.957909943901572 1.0 1.0 2 P31749 1 |
| Cell cycle 0.2558675677957692 0.0508600210089973 0.9594370628686436 1.0 1.0 42 P27348,P33981,Q14566,P11802,P31946,P61981,Q9UBD5,P06493,Q04917,Q9Y619,Q9UJX3,Q9UJX2,P53350,P62258,P30260,Q99640,Q92769 17 |
| Mechanoregulation and pathology of yaptaz via hippo and nonhippo mechanisms 0.2926366700747813 0.0385858867649529 0.9692205546436504 1.0 1.0 6 P35221,Q13043 2 |
| Vitamin b12 disorders 0.3478888487910421 0.0326697226576505 0.9739379688159931 1.0 1.0 2 Q96EY8 1 |
| Tcell activation sarscov2 0.2491498193094503 0.0251571029545096 0.979929653000025 1.0 1.0 15 O15111,P49815,P62993,O95999 4 |
| Tp53 network 0.370036101083027 0.02100306823569 0.9832432081184366 1.0 1.0 3 Q07812,P04637 2 |
| Mfap5mediated ovarian cancer cell motility and invasiveness 0.3245487364620886 0.0110585152953857 0.9911767612142062 1.0 1.0 3 P27361,P19174 2 |
| Ebsteinbarr virus lmp1 signaling 0.3246659443842497 0.0105364754567007 0.991593264456976 1.0 1.0 4 O15111,O43318,P07900 3 |
| Osteopontin signaling 0.32466594438425 0.0105364754567007 0.991593264456976 1.0 1.0 4 O15111,Q02750,P27361 3 |
| 15q133 copy number variation syndrome 0.3032490974729172 0.0088249028757516 0.9929588376379808 1.0 1.0 3 Q9BXW9,P50454 2 |
| Peroxiredoxin 2 induced ovarian failure 0.3025983859569337 0.0013787897506209 0.9988998852939506 1.0 1.0 4 P42574 1 |
|
|
